SCHEMBL29832355

SCHEMBL29832355

NC1(O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.64
▸ KMT2A Q03164 2/20 0.64
▸ LGALS8 O00214 1/20 0.46
▸ LGALS3 P17931 1/20 0.46
▸ LGALS4 P56470 1/20 0.46
▸ GJA1 P17302 1/20 0.45
▸ GJB2 P29033 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ TYR P14679 2/20 0.44
▸ PTPN1 P18031 1/20 0.43
▸ IGF2R P11717 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ SYNJ2 O15056 1/20 0.41
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31174646 0.84 MEN1 (0.63) MEN1KMT2ALGALS8LGALS3LGALS4
SCHEMBL30998836 0.83 MEN1 (0.64) MEN1KMT2ALGALS8LGALS3LGALS4
SCHEMBL14444676 0.83 MEN1 (0.64) MEN1KMT2ALGALS8LGALS3LGALS4
SCHEMBL29854677 0.83 MEN1 (0.64) MEN1KMT2ALGALS8LGALS3LGALS4
SCHEMBL14209162 0.83 MEN1 (0.64) MEN1KMT2ALGALS8LGALS3LGALS4
SCHEMBL157303 0.83 MEN1 (0.64) MEN1KMT2ALGALS8LGALS3LGALS4
SCHEMBL30094014 0.82 MEN1 (0.67) MEN1KMT2ALGALS8LGALS3LGALS4
SCHEMBL464650 0.82 MEN1 (0.63) MEN1KMT2ALGALS8LGALS3LGALS4
SCHEMBL20000766 0.81 MEN1 (0.62) MEN1KMT2ALGALS8LGALS3LGALS4
SCHEMBL6823456 0.81 MEN1 (0.70) MEN1KMT2ALGALS8LGALS3LGALS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119569914-A Impregnating solution, preparation method thereof, antibacterial fiber, antibacterial fabric and application 南京林业大学 2025-03-07 — — CN disclosed
WO-2025015394-A1 COMPOSITION OF CARBON DOTS COMPRISING A CORE FORMED BY CARBOHYDRATES AND A SURFACE COMPRISING CARBOXYLIC ACID OR TERMINAL ALKYNE FUNCTIONAL GROUPS, METHOD OF PREPARATION THEREOF AND USE THEREOF SÃO MARTINHO S.A. (BR) 2025-01-23 — — WO disclosed
US-20240173374-A1 LIPOSOMAL FORMULATIONS OF BORONIC ACID CONTAINING ACTIVE AGENTS OHIO STATE INNOVATION FOUNDATION 2024-05-30 — — US disclosed
US-20230304998-A1 CELLULAR MATERIAL DETECTION PROBES FluoretiQ Limited (GB) 2023-09-28 — — US disclosed
WO-2022182993-A1 LIPOSOMAL FORMULATIONS OF BORONIC ACID CONTAINING ACTIVE AGENTS OHIO STATE INNOVATION FOUNDATION (US) 2022-09-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240173374-A1 LIPOSOMAL FORMULATIONS OF BORONIC ACID CONTAINING ACTIVE AGENTS LIPA, CHMP4B, VMA21 MEN1 320/4885KMT2A 1249/4885LGALS8 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback